Biotechnology asset referenced as IBA; the specific company and security are not identified clearly in the discussion.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about International Biotech.
The 1 sources with the most insights about International Biotech on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Shkreli said he was short a small amount, reasoning that the drug mechanism had not succeeded in the disease despite prior attempts. The program and comparability of earlier efforts were not specified.
Shkreli said he was short a small amount, reasoning that the drug mechanism had not succeeded in the disease despite prior attempts. The program and comparability of earlier efforts were not specified.
Other assets that creators frequently mention in the same content as International Biotech.
The most active sources covering International Biotech (IBA) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about International Biotech (IBA) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering International Biotech (IBA) most frequently also discuss INTC, AMD, LRCX, GRAL, KOD. See the "Discussed alongside" section above for full asset pages.